Biocon Share Price

Biocon Share Price

NSE: BIOCON

|

BSE: 532523

|

Pharmaceuticals

60% Buy

₹352.25

-₹2.20 (-0.62%) Last updated on 12 Jun, 2025 | 15:54 IST

Biocon Overview

Market cap
Market Cap Switch₹40,878 Crs
Open
₹355.00
Prev. Close
₹354.45
Circuit range
₹389.85 - ₹319.00
Day range
₹349.50 - ₹357.75
Year range
₹291.00 - ₹404.70
Volume
42,65,927
Avg. traded
₹354.13
Revenue (12m)
₹15,262 Crs

About Biocon

Biocon India Pvt Ltd is a biotechnology company engaged in all phases of the product cycle from the discovery to the development and commercialisation of the drug.

The company was incorporated as a joint venture between Kiran Mazumdar-Shaw and Biocon Biochemicals Ltd Ireland in 1978. The company started in Bengaluru with just three employees. It began manufacturing and exporting papain, a plant enzyme, and isinglass, a marine hydrocolloid – both key products for the brewing industry.

Two years later, Biocon laid the foundation of its campus in Bengaluru to expand its operation. The building to date is home to the company's corporate office. In 1984, a year after the construction of the company's head office, Biocon established its R&D division, which initially focused on the development of solid-state fermentation technology to develop novel enzymes.

In 1989, Biocon Biochemicals Ltd, Ireland, along with its subsidiaries was acquired by Unilever plc and merged with its wholly-owned subsidiary Quest International. This paved the way for Biocon India to produce enzymes for Unilever’s food businesses.

Business operations

Biocon India became the first life science company in the country to get ISO 9001 Certification. The company incorporated Syngene as a custom research organisation (CRO) in 1994 to provide efficient, high-quality, cost-effective research and development services in chemistry and biology.

In 1998, Biocon became an independent company after Kiran Mazumdar-Shaw and John Shaw bought Unilever’s share in the company.

At the turn of the century, Biocon established Clinigene as India's first clinical research organisation.

In 2002, Biocon established a joint venture company, Biocon Biopharmaceuticals Pvt Ltd, with CIMAB S.A., a Cuban biotechnology company.

Biocon went public with a successful IPO in 2004. On the day of the listing, the company crossed a market value of $1.1 billion, making Biocon only the second Indian company to do so.

In 2006, the company inaugurated Biocon Park, India's first biotechnology special economic zone (SEZ).

Biocon divested its legacy enzymes business to Novozymes for $115 million in 2007 to increase focus on developing, and manufacturing biopharmaceuticals.

Biocon launched Insulin Glargine under the brand name Basalog in India in 2009, offering diabetes patients an advanced, affordable insulin therapy. The company’s research organisation, Syngene made a debut on the Indian stock market in 2015.

Biocon Biologics approved a primary equity investment by True North in 2020. The same year, Tata Capital picked up a minority stock in Biocon Biologics. Biocon Biologics also received a $150 million capital injection from Goldman Sachs.

Biocon's market capitalisation stands at over ₹30,399 crore as of December 20, 2023. Biocon Ltd's share price has plunged over 47% in the last three years.

Financial Highlights

The total income of the company for FY23 stood at ₹11,550 crore, up by 38% year-on-year. The firm reported a profit of ₹462.7 crore in FY23. The EBITDA (earnings before interest, taxes, depreciation and amortisation) stood at ₹2,887.6 crore in FY23. The EBITDA margin stood at 25% in FY23. The company made a total capital expenditure of ₹530 crore in FY23. Its earnings per share (EPS) increased to ₹3.9 in FY23.

  • Chart
  • Fundamentals
  • Financials
  • F&O
  • Shareholdings
  • Events
  • Peers
  • News
  • FAQs

Biocon Share Price Chart

Please wait...

Biocon Key Indicators

P/E ratio
40.33
P/B ratio
1.83
ROE
1.1%
ROCE
2.77%
Dividend yield
0.15%
Debt/Equity ratio
0.19
EPS
0.99

Investment Checklist: (2/6)

not passed

Equity returns

not passed

Dividend returns

passed

Safety factor

NA

Growth factor

passed

Debt vs Equity

NA

Profit factor

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Analyst Ratings:

Buy

Buy

60%

Hold

20%

Sell

20%

This analysis is based on the reviews of 15 experts in the last 7 days

Biocon Financial Ratios

  • Profitability

  • Operational

  • Valuation

Operating profit margin

21.42%

Net profit margin

5.61%

ROE

1.1%

ROA

0.89%

ROCE

2.77%

Biocon Shareholder returns

1 day
+3.88%
1 week
+5.37%
1 month
+7.44%
3 months
+7.77%
1 year
+2.90%
3 years
+4.56%
5 years
-8.40%

Revenue Statement

All values are in ₹ Crores (Cr)
RevenueNo Sort
Operating ProfitNo Sort
Net ProfitNo Sort
Mar-24
14,755.70
4,164.20
1,297.80
Mar-23
11,174.20
2,887.60
643.00
Mar-22
8,184.00
2,182.90
771.60
Mar-21
7,143.10
1,907.30
846.20

Cash Flow

All values are in ₹ Crores (Cr)
OperatingNo Sort
InvestingNo Sort
FinancingNo Sort
Mar-24
2,953.90
-1,004.5
-2332.70
Mar-23
1,852.50
-14,281.8
13048.70
Mar-22
1,176.60
-1,699.1
242.10
Mar-21
1,159.70
-3,624.7
2564.00

Balance Sheet

All values are in ₹ Crores (Cr)
Total AssetNo Sort
Total LiabilityNo Sort
Mar-24
55,753.40
30,478.60
Mar-23
51,741.80
29,253.00
Mar-22
20,100.70
10,630.70
Mar-21
18,214.60
9,707.00

Biocon Share Price History

DayOpenCloseChange %
12-Jun-25
₹355.00
₹352.25
-0.62%
11-Jun-25
₹341.20
₹354.45
+3.88%
10-Jun-25
₹339.80
₹341.20
+0.90%
09-Jun-25
₹332.90
₹338.15
+2.45%
06-Jun-25
₹331.95
₹330.05
-0.17%
05-Jun-25
₹335.10
₹330.60
-1.72%
04-Jun-25
₹338.50
₹336.40
-0.24%
03-Jun-25
₹340.00
₹337.20
+0.96%

Biocon Shareholding Pattern

Promoters (60.64%)

Mutual Funds (8.77%)

Retail and other (17.97%)

Foreign institutions-FII (5.67%)

Other domestic institutions (6.94%)

Promoters

Corporate Actions

  • Dividend • ₹0.5/share

    Ex date 05 Jul 2024

    expand tab
  • Dividend • ₹1.5/share

    Ex date 07 Jul 2023

    expand tab

Stocks Similar to Biocon

PriceNo Sort
Change %No Sort
Abbott India₹31,575.00-₹60.00 (-0.19%)
Alkem Laboratories₹4,846.50-₹39.00 (-0.8%)
Aurobindo Pharma₹1,155.20-₹5.80 (-0.5%)
Cipla₹1,502.80-₹18.90 (-1.24%)
Gland Pharma₹1,651.50-₹30.30 (-1.8%)
Lupin₹2,023.20-₹3.40 (-0.17%)
Piramal Enterprises₹1,153.20-₹22.90 (-1.95%)
Torrent Pharmaceuticals₹3,258.80+₹53.00 (1.65%)
Zydus Lifesciences₹978.80+0.00 (0.00%)

Popular Stocks

PriceNo Sort
Change %No Sort
HDFC Bank₹1,943.40-₹7.00 (-0.36%)
Indian Railway Finance Corp₹140.47-₹4.98 (-3.42%)
ITC₹421.00-₹5.15 (-1.21%)
JIO FIN SERVICES LTD₹296.00-₹6.65 (-2.2%)
Reliance₹1,441.60-₹7.30 (-0.5%)
Tata Motors₹715.35-₹21.05 (-2.86%)
Tata Power₹401.65-₹10.40 (-2.52%)
Tata Steel₹152.89-₹3.52 (-2.25%)
Wipro₹259.61+₹0.69 (0.27%)
YES Bank₹20.42-₹0.29 (-1.4%)

FAQs on Biocon

What is the share price of Biocon today?

chevron-up
Biocon share price is ₹ 352.25 as on 12 Jun, 2025 | 15:54 IST.

What are the high & low stock price of Biocon today?

chevron-up
Biocon stock price hit a high of ₹ 357.75 and low of ₹ 349.50 as on 12 Jun, 2025 | 15:54 IST.

What is the market cap of Biocon?

chevron-up
The market cap of Biocon is ₹ 40,877.91 Crores as on 12 Jun, 2025 | 15:54 IST.

What are the the 52-week high and low share prices of Biocon stock on the NSE?

chevron-up
52-week high stock Price of Biocon is ₹ 404.70 and Low Price is ₹ 291.00 as on 12 Jun, 2025 | 15:54 IST.

What are the stock symbols of Biocon?

chevron-up
The stock symbol of Biocon is NSE: BIOCON on the NSE, BSE: 532523 on the BSE, and the ISIN is INE376G01013.

Can I buy Biocon shares on Holidays?

chevron-up
No, shares of Biocon or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Biocon shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.

What is the PE and PB ratio of Biocon?

chevron-up
The PE and PB ratio of Biocon is 40.33 and 1.83 respectively, as on 12 Jun, 2025 | 15:54 IST.

What are the returns on Biocon shares?

chevron-up
The historical returns for Biocon shares are 2.9 for 1 year, 4.56 for 3 year and -8.4 for 5 year.